Recombinant Human AKR1C2 Protein，His

AKR1C2, a member of the aldo-keto reductase (AKR) superfamily, plays a significant role in the metabolism of steroid hormones, prostaglandins, and various xenobiotics. Research into AKR1C2 has garnered attention due to its implications in several physiological and pathological processes, including hormone regulation, cancer progression, and metabolic disorders. The enzyme is involved in the reduction of androstenedione to testosterone, highlighting its importance in androgen metabolism, which can impact prostate cancer and other hormone-related diseases. Furthermore, AKR1C2 has been implicated in the detoxification processes of reactive carbonyl species, underscoring its potential role in cellular protection against oxidative stress. The recombinant expression of AKR1C2 has enabled more detailed studies on its enzymatic properties, substrate specificity, and potential as a therapeutic target. Investigating the structure-function relationship of AKR1C2 through techniques such as crystallography and mutagenesis has provided insights into its molecular mechanisms and interaction with various ligands. Given the increasing awareness of the enzyme's role in drug metabolism and disease, further research into AKR1C2 may pave the way for novel therapeutic strategies and biomarkers for disease prognosis. This highlights the necessity of continued exploration into its functional characteristics and regulatory mechanisms, which could ultimately facilitate advancements in personalized medicine and treatment modalities for conditions influenced by steroid hormone metabolism.